Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6521-6531

  Haroon, Fahad ^a   Drögemüller, Katrin ^a   Händel, Ulrike ^a   Brunn, Anna ^b   Reinhold, Dirk ^a   Nishanth, Gopala ^a   Mueller, Werner ^c   Trautwein, Christian ^d   Ernst, Matthias ^e   Deckert, Martina ^b   Schlüter, Dirk ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 130; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; PROTEIN SH2; RAS PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LOSS; CELL SURFACE; CONTROLLED STUDY; DEMYELINATION; DIMERIZATION; DISEASE SEVERITY; IMMUNIZATION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; ASTROCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CYTOKINE RECEPTOR GP130; CYTOKINES; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; RAS PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 79958042327     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001135     Document Type: Article

References (57)

1. Tani, M., A. R. Glabinski, V. K. Tuohy, M. H. Stoler, M. L. Estes, and R. M. Ransohoff. 1996. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 148: 889-896.
2. Brambilla, R., T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea. 2009. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182: 2628-2640.
3. van Loo, G., R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassmann, M. R. Prinz, and M. Pasparakis. 2006. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7: 954-961.
4. Kang, Z., C. Z. Altuntas, M. F. Gulen, C. Liu, N. Giltiay, H. Qin, L. Liu, W. Qian, R. M. Ransohoff, C. Bergmann, et al. 2010. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32: 414-425.
5. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.
6. Hardin-Pouzet, H., M. Krakowski, L. Bourbonnière, M. Didier-Bazes, E. Tran, and T. Owens. 1997. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20: 79-85. (Pubitemid 27207010)
7. Bannerman, P., A. Hahn, A. Soulika, V. Gallo, and D. Pleasure. 2007. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 55: 57-64. (Pubitemid 44845509)
8. Nair, A., T. J. Frederick, and S. D. Miller. 2008. Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65: 2702-2720.
9. Kohji, T., and Y. Matsumoto. 2000. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 106: 165-171. (Pubitemid 30256089)
10. Voskuhl, R. R., R. S. Peterson, B. Song, Y. Ao, L. B. Morales, S. Tiwari-Woodruff, and M. V. Sofroniew. 2009. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29: 11511-11522.
11. Fitzgerald, D. C., B. Ciric, T. Touil, H. Harle, J. Grammatikopolou, J. Das Sarma, B. Gran, G. X. Zhang, and A. Rostami. 2007. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 179: 3268-3275.
12. Trajkovic, V., O. Vuckovic, S. Stosic-Grujicic, D. Miljkovic, D. Popadic, M. Markovic, V. Bumbasirevic, A. Backovic, I. Cvetkovic, L. Harhaji, et al. 2004. Astrocyte-induced regulatory T cells mitigate CNS autoimmunity. Glia 47: 168-179. (Pubitemid 39049990)
13. Gimsa, U., A. ØRen, P. Pandiyan, D. Teichmann, I. Bechmann, R. Nitsch, and M. C. Brunner-Weinzierl. 2004. Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). J. Mol. Med. 82: 364-372.
14. Sofroniew, M. V., and H. V. Vinters. 2010. Astrocytes: biology and pathology. Acta Neuropathol. 119: 7-35.
15. Ernst, M., and B. J. Jenkins. 2004. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20: 23-32.
16. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936.
17. Eugster, H. P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6- deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28: 2178-2187.
18. Linker, R. A., M. Mäurer, S. Gaupp, R. Martini, B. Holtmann, R. Giess, P. Rieckmann, H. Lassmann, K. V. Toyka, M. Sendtner, and R. Gold. 2002. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8: 620-624.
19. Butzkueven, H., J. G. Zhang, M. Soilu-Hanninen, H. Hochrein, F. Chionh, K. A. Shipham, B. Emery, A. M. Turnley, S. Petratos, M. Ernst, et al. 2002. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8: 613-619.
20. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349-1353.
21. Tebbutt, N. C., A. S. Giraud, M. Inglese, B. Jenkins, P. Waring, F. J. Clay, S. Malki, B. M. Alderman, D. Grail, F. Hollande, et al. 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8: 1089-1097.
22. Ohtani, T., K. Ishihara, T. Atsumi, K. Nishida, Y. Kaneko, T. Miyata, S. Itoh, M. Narimatsu, H. Maeda, T. Fukada, et al. 2000. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 12: 95-105. (Pubitemid 30069218)
23. Bajenaru, M. L., Y. Zhu, N. M. Hedrick, J. Donahoe, L. F. Parada, and D. H. Gutmann. 2002. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell. Biol. 22: 5100-5113.
24. Betz, U. A., W. Bloch, M. van den Broek, K. Yoshida, T. Taga, T. Kishimoto, K. Addicks, K. Rajewsky, and W. Müller. 1998. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J. Exp. Med. 188: 1955-1965.
25. Zhu, Y., M. I. Romero, P. Ghosh, Z. Ye, P. Charnay, E. J. Rushing, J. D. Marth, and L. F. Parada. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15: 859-876.
26. Steinbrecher, A., D. Reinhold, L. Quigley, A. Gado, N. Tresser, L. Izikson, I. Born, J. Faust, K. Neubert, R. Martin, et al. 2001. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J. Immunol. 166: 2041-2048. (Pubitemid 32114693)
27. Schlüter, D., J. Löhler, M. Deckert, H. Hof, and G. Schwendemann. 1991. Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J. Neuroimmunol. 31: 185-198.
28. Rosen, G. D., and J. D. Harry. 1990. Brain volume estimation from serial section measurements: a comparison of methodologies. J. Neurosci. Methods 35: 115-124.
29. Schlüter, D., S. B. Oprisiu, S. Chahoud, D. Weiner, O. D. Wiestler, H. Hof, and M. Deckert-Schlüter. 1995. Systemic immunization induces protective CD4+ and CD8+ T cell-mediated immune responses in murine Listeria monocytogenes meningoencephalitis. Eur. J. Immunol. 25: 2384-2391.
30. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-D D C(T)) method. Methods 25: 402-408.
31. Drögemüller, K., U. Helmuth, A. Brunn, M. Sakowicz-Burkiewicz, D. H. Gutmann, W.Mueller,M. Deckert, and D. Schlüter. 2008.Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J. Immunol. 181: 2683-2693.
32. Pender, M. P., and M. J. Rist. 2001. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36: 137-144.
33. Klein, C., T. Wüstefeld, U. Assmus, T. Roskams, S. Rose-John, M. Müller, M. P. Manns, M. Ernst, and C. Trautwein. 2005. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J. Clin. Invest. 115: 860-869.
34. Linker, R. A., N. Kruse, S. Israel, T. Wei, S. Seubert, A. Hombach, B. Holtmann, F. Luhder, R. M. Ransohoff, M. Sendtner, and R. Gold. 2008. Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation. J. Immunol. 180: 2204-2213.
35. Streetz, K. L., T. Wüstefeld, C. Klein, K. J. Kallen, F. Tronche, U. A. Betz, G. Schütz, M. P. Manns, W. Müller, and C. Trautwein. 2003. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125: 532-543. (Pubitemid 36929435)
36. Renno, T., M. Krakowski, C. Piccirillo, J. Y. Lin, and T. Owens. 1995. TNFalpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines. J. Immunol. 154: 944-953.
37. Ozawa, K., G. Suchanek, H. Breitschopf, W. Brück, H. Budka, K. Jellinger, and H. Lassmann. 1994. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322.
38. Ransohoff, R. M., T. A. Hamilton, M. Tani, M. H. Stoler, H. E. Shick, J. A. Major, M. L. Estes, D. M. Thomas, and V. K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7: 592-600.
39. Pender, M. P., K. B. Nguyen, P. A. McCombe, and J. F. Kerr. 1991. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104: 81-87.
40. Schmied, M., H. Breitschopf, R. Gold, H. Zischler, G. Rothe, H. Wekerle, and H. Lassmann. 1993. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143: 446-452.
41. Bonetti, B., J. Pohl, Y. L. Gao, and C. S. Raine. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159: 5733-5741.
42. Bechmann, I., B. Steiner, U. Gimsa, G. Mor, S. Wolf, M. Beyer, R. Nitsch, and F. Zipp. 2002. Astrocyte-induced T cell elimination is CD95 ligand dependent. J. Neuroimmunol. 132: 60-65. (Pubitemid 35333326)
43. Faulkner, J. R., J. E. Herrmann, M. J. Woo, K. E. Tansey, N. B. Doan, and M. V. Sofroniew. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24: 2143-2155.
44. Menet, V., M. Prieto, A. Privat, and M. Giménez y Ribotta. 2003. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. USA 100: 8999-9004.
45. McGeachy, M. J., L. A. Stephens, and S. M. Anderton. 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
46. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
47. Becher, B., B. G. Durell, and R. J. Noelle. 2003. IL-23 produced by CNSresident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 112: 1186-1191.
48. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFNgamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7.
49. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160: 2940-2946.
50. Siglienti, I., A. Chan, C. Kleinschnitz, S. Jander, K. V. Toyka, R. Gold, and G. Stoll. 2007. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. J. Neuropathol. Exp. Neurol. 66: 47-56.
51. Sun, D., C. Coleclough, L. Cao, X. Hu, S. Sun, and J. N. Whitaker. 1998. Reciprocal stimulation between TNF-alpha and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 89: 122-130.
52. Faunce, D. E., A. Terajewicz, and J. Stein-Streilein. 2004. Cutting edge: in vitrogenerated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 172: 1991-1995. (Pubitemid 38182341)
53. Atsumi, T., K. Ishihara, D. Kamimura, H. Ikushima, T. Ohtani, S. Hirota, H. Kobayashi, S. J. Park, Y. Saeki, Y. Kitamura, and T. Hirano. 2002. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 196: 979-990.
54. Aggarwal, B. B., G. Sethi, K. S. Ahn, S. K. Sandur, M. K. Pandey, A. B. Kunnumakkara, B. Sung, and H. Ichikawa. 2006. Targeting signal-transducer-and- activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann. N. Y. Acad. Sci. 1091: 151-169.
55. Herrmann, J. E., T. Imura, B. Song, J. Qi, Y. Ao, T. K. Nguyen, R. A. Korsak, K. Takeda, S. Akira, and M. V. Sofroniew. 2008. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28: 7231-7243.
56. Bromberg, J., and J. E. Darnell, Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468-2473.
57. Nakaoka, Y., K. Nishida, Y. Fujio, M. Izumi, K. Terai, Y. Oshima, S. Sugiyama, S. Matsuda, S. Koyasu, K. Yamauchi-Takihara, et al. 2003. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ. Res. 93: 221-229.